Regenerative Medicine – Market Insights – United States
The US market for regenerative medicine therapies consists of relatively new products in expanding markets and emerging technologies that will form new segments. The market is expected to undergo enormous growth once the first products enter the market due to the high prices of these therapies and the large patient populations for the treatments, as well as their ability to address the unmet needs of patient populations with rare diseases for which there are few alternative treatments.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for regenerative medicine in the US across a 10-year period, with additional coverage through 2027 for some segments.
There are enormous market opportunities for gene and cell therapies.
How will prices and reimbursement impact the regenerative medicine market?
When will the majority of treatments come to market?
How many procedures will be performed by the end of the forecast period?
What challenges will companies face in terms of competing in these emerging segments?
There are currently very few approved regenerative medicine therapies in the US.
Which indications have the highest patient populations?
How quickly will treatments be adopted for different diseases?
There is a significant variety of diseases that can be treated by both gene and cell therapies.
For which indications will regenerative therapies become available first?
How will the companies that are first-to-market impact the regenerative medicine market as a whole?
What challenges will companies face in terms of competing in these emerging segments?
Table of contents
- Regenerative Medicine - Market Insights - United States
- Abstract
- Executive Summary
- Market Highlights
- Factors Impacting the Regenerative Medicine Market, by Product Type, US
- Regenerative Medicine Market Scenario Forecast, US (USD), 2015u20132025
- Regenerative Medicine Market Landscape, US (USD), 2018 and 2027
- Competitive Highlights
- Competitive Factors and Strategies, by Product Type, US
- Companies Mentioned
- Market Developments
- Recent Events in the Regenerative Medicine Market, US
- Emerging Products for the Regenerative Medicine Market, US
- Products and Procedures Covered
- Regenerative Medicine Products and Procedures Covered, US
- Market Highlights
- Version History
- Regenerative Medicine Market
- Market Highlights
- Factors Impacting the Regenerative Medicine Market, by Product Type, US
- Regenerative Medicine Market Scenario Forecast, US (USD), 2015u20132025
- Market Definitions
- Market Forecast Data
- Regenerative Medicine Market, by Therapy Type, US (USD), 2015u20132025
- Regenerative Medicine Market Growth, by Therapy Type, US, 2015u20132025
- General Market Trends
- Competitive Highlights
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, US
- Market Developments
- Recent Events in the Regenerative Medicine Market, US
- Emerging Products for the Regenerative Medicine Market, US
- Market Highlights
- Gene Therapy Market
- Market Highlights
- Gene Therapy Market Scenario Forecast, US (USD), 2017u20132027
- Market Definitions
- Market Forecast Data
- Potential Gene Therapy Patient Pool, By Availability of Alternative Treatment, US, 2015u20132027
- Potential Gene Therapy Patient Pool Growth, By Availability of Alternative Treatment, US, 2019u20132027
- Scenario Forecast for Gene Therapy Procedures, By Availability of Alternative Treatment, US, 2015u20132027
- Scenario Forecast for Gene Therapy Procedure Growth, By Availability of Alternative Treatment, US, 2019u20132027
- Scenario Forecast for Gene Therapy Market, US (USD), 2015u20132027
- Scenario Forecast for Gene Therapy Market Growth, US, 2019u20132027
- General Market Trends
- Competitive Highlights
- Competitive Factors and Strategies
- Competitive Factors and Strategies, US
- Product Pipeline
- Product Pipeline, Gene Therapy Market
- Market Highlights
- Cell Therapy Market
- Market Highlights
- Cell Therapy Market Scenario Forecast, US (USD), 2017u20132027
- Market Definitions
- Market Forecast Data
- Potential Cell Therapy Patient Pool, By Availability of Alternative Treatment, US, 2015u20132027
- Potential Cell Therapy Patient Pool Growth, By Availability of Alternative Treatment, US, 2019u20132027
- Scenario Forecast for Cell Therapy Procedures, By Availability of Alternative Treatment, US, 2015u20132027
- Scenario Forecast for Cell Therapy Procedure Growth, By Availability of Alternative Treatment, US, 2019u20132027
- Scenario Forecast for Cell Therapy Market, US (USD), 2017u20132027
- Scenario Forecast for Cell Therapy Market Growth, US, 2019u20132027
- Competitive Highlights
- Competitive Factors and Strategies
- Competitive Factors and Strategies, US
- Product Pipeline
- Product Pipeline, Cell Therapy Market
- Market Highlights
- Tissue Therapy Market
- Market Highlights
- Tissue Therapy Market, by Procedure Type, US (USD), 2015u20132025
- Market Definitions
- Market Forecast Data
- Tissue Therapy Procedures, by Procedure Type, US, 2015u20132025
- Tissue Therapy Market, by Procedure Type, US (USD), 2015u20132025
- Tissue Therapy Market Growth, by Procedure Type, US, 2016u20132025
- Orthopedic Market, by Product Type, US (USD), 2015u20132025
- Orthopedic Growth Factor Market, US (USD), 2015u20132025
- Orthopedic Stem Cell Product Market, US (USD), 2015u20132025
- ACI Market, US (USD), 2015u20132025
- Soft Tissue Procedures, by Product Type, US, 2015u20132025
- Soft Tissue Market, by Product Type, US (USD), 2015u20132025
- Soft Tissue Market Growth, by Product Type, US, 2016u20132025
- General Market Trends
- Competitive Highlights
- Market Shares
- Tissue Therapy Revenue Market Shares, US, 2016
- Tissue Therapy Revenue Market Shares, by Procedure Type, US, 2016
- Orthopedic Revenue Market Shares, by Product Type, US, 2016
- Soft Tissue Revenue Market Shares, by Product Type, US, 2016
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Procedure Type, US
- Product Pipeline
- Product Pipeline, Tissue Therapy Market
- Market Highlights
- Methodology
- Core Country Coverage Methodology
- Supplemental Country Coverage Methodology
- Core Country Coverage Methodology
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Benjamin Li is a team lead within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, with extensive knowledge in healthcare IT, women’s health imaging, urology, large-joint reconstruction, spinal implants, and dental implants. Benjamin holds a Bachelor’s degree in Business Administration from the Schulich School of Business, with a certificate in Managing International Trade and Investment.